Height and kidney cancer risk: a meta-analysis of prospective studies

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 10, 2015, Pages 1799-1807

  Liang, Sudong ^a   Lv, Gaofei ^b   Chen, Weikai ^a   Jiang, Jianxin ^a   Wang, Jingqun ^a  

^a Gaoyou Hospital Affiliated Soochow University   (China)

^b Department of Urology Yongzhou Central Hospital Affiliated to Nanhua University   (China)

Author keywords

Body size; Height; Kidney cancer; Meta analysis; Renal cancer

Indexed keywords

ALCOHOL CONSUMPTION; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; HEIGHT; HUMAN; KIDNEY CANCER; META ANALYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING; BODY HEIGHT; KIDNEY NEOPLASMS; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RISK; RISK FACTOR;

BODY HEIGHT; HUMANS; KIDNEY NEOPLASMS; PROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 84939571484     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1870-5     Document Type: Review

References (36)

1. Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow W-H (2008) Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 168:268–277
2. Marmot M et al (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective
3. Aune D et al (2012) Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies. Cancer Causes Control 23:1213–1222
4. Batty G, Shipley M, Langenberg C, Marmot M, Smith GD (2006) Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 17:157–166
5. Batty G et al (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration Annals of oncology 21:646–654
6. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 1088–1101
7. Ben-Shlomo Y, Holly J, McCarthy A, Savage P, Davies D, Smith GD (2005) Prenatal and postnatal milk supplementation and adult insulin-like growth factor I: long-term follow-up of a randomized controlled trial. Cancer Epidemiol Biomark Prev 14:1336–1339
8. Bjørge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168–1176
9. Cheung CW, Vesey DA, Nicol DL, Johnson DW (2004) The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 65:1272–1279
10. Chow W-H, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer Nature Reviews. Urology 7:245–257
11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials controlled clinical trials 7:177–188
12. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
14. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12:785–794
15. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 135:1301–1309
16. Hamling J, Lee P, Weitkunat R, Ambühl M (2008) Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 27:954–970
17. Higgins J, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
18. Kabat GC et al (2013a) Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomark Prev 22:1353–1363
19. Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE (2013b) Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 132:1125–1132
20. Major J, Pollak M, Snyder K, Virtamo J, Albanes D (2010) Insulin-like growth factors and risk of kidney cancer in men. Br J Cancer 103:132–135
21. Pischon T et al (2006) Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118:728–738
22. Rasmuson T, Grankvist K, Jacobsen J, Olsson T, Ljungberg B (2004) Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 43:744–748
23. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353
24. Rogers I, Metcalfe C, Gunnell D, Emmett P, Dunger D, Holly J (2006) Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab 91:2514–2519
25. Setiawan VW, Stram DO, Nomura AM, Kolonel LN, Henderson BE (2007) Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 166:932–940
26. Silventoinen K (2003) Determinants of variation in adult body height. J Biosoc Sci 35:263–285
27. Stewart AL (1982) The reliability and validity of self-reported weight and height. J Chronic Dis 35:295–309
28. Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283:2008–2012
29. Tang R-Q, Zheng W, Li H-L, Gao Y-T, Shu X-O, Xiang Y-B (2012) Prospective cohort study of body height and cancer incidence among adult men and women in Shanghai. Tumor 32:992–1000
30. Tripaldi R, Stuppia L, Alberti S (2013) Human height genes and cancer. Biochim Biophys Acta Rev Cancer 1836:27–41
31. Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomark Prev 6:863–873
32. Van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, Van den Brandt PA (2004) Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study. Am J Epidemiol 160:1159–1167
33. Walter RB, Brasky TM, Buckley SA, Potter JD, White E (2013) Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 105:860–868
34. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
35. Wirén S et al (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159
36. Zuccolo L et al (2008) Height and prostate cancer risk: a large nested case–control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomark Prev 17:2325–2336